No abstract available
MeSH terms
-
Cadaver
-
Cost-Benefit Analysis
-
Hospitalization / economics
-
Humans
-
Immunosuppression Therapy / economics
-
Immunosuppressive Agents / economics
-
Kidney Diseases / therapy*
-
Kidney Transplantation / immunology*
-
Muromonab-CD3 / economics*
-
Muromonab-CD3 / therapeutic use
-
Peritoneal Dialysis / economics
-
Survival Analysis
Substances
-
Immunosuppressive Agents
-
Muromonab-CD3